Scimar

Scimar

Closed: Jun. 2024

About this raise

Scimar is raising funds on Texture Capital through Reg A+ crowdfunding. The company discovered the hepatalin hormone and is revolutionizing the prevention, diagnosis, and treatment of type 2 diabetes. Scimar is developing medical interventions based on the science of hepatalin to handle excess glucose in the body and bring an end to type 2 diabetes. The company has currently conceived four products, including SciMar NuPa Test, SciMar NuPa Daily, SciMar NuPa Renew, and Hepatalin-S, and plans to grow more. Dr. W. Wayne Lautt and Mick Lautt founded Scimar in 2009. The current crowdfunding campaign has a maximum target of $55 million. The campaign proceeds will be used for research and development, expanded infrastructure, cost of capital, facilities, operations, brand building, and accounting expenses.

Expand

Investment Overview

Invested this round: $358,639

Deal Terms

Total Commitments

Platform
Texture Capital
Start Date
12/21/2023
Close Date
Not Provided
Min. Goal
$99
Max Goal
$55,000,000
Min. Investment

$99

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$5.50

Pre-Money Valuation

$478,866,592

Company & Team

Company

Year Founded
2009
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
High
Location
Dauphin, Manitoba
Business Type
Growth
Company Website
Visit Website

Team

Employees
14
Prior Founder Exits?
No
Founder Name
Dr. Wayne Lautt
Title
Chief Scientific Officer
Founder Name
Mick Lautt
Title
CEO

Financials

 Revenue
$3,028
 Monthly Burn
$595,091
 Runway
0.3 months

Balance Sheet

Cash and Cash Equivalents

$170,892

Investment Securities

$534,916

Accounts and Notes Receivable

$1,750,342

Property, Plant and Equipment (PP&E)

$206,486

Property and Equipment

$206,486

Total Assets

$3,272,001

Accounts Payable & Accrued Liabilities

$1,614,373

Long Term Debt

$40,000

Total Liabilities

$14,985,567

Total Stockholders' Equity

$-11,713,566

Total Liabilities and Equity

$3,272,001

Statement of Comprehensive Income Information

Total Revenues

$3,028

Costs & Expenses Applicable to Rev

$136,728

Depreciation and Amortization

$209,181

Net Income

$-7,141,089

Earnings Per Share - Basic

$-0.12

Earnings Per Share - Diluted

$-0.12

Auditor: KPMG
Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$19,630,000
Grants
$17,300,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
06/26/2024 Texture Capital $478,866,592 $358,639 Equity - Common Funded RegA+
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Scimar on Texture Capital 2024
Platform: Texture Capital
Security Type: Equity - Common
Valuation: $478,866,592
Price per Share: $5.50

Follow company

Follow Scimar on Texture Capital 2024

Buy Scimar's Deal Report

Warning: according to the close date for this deal, Scimar may no longer be accepting investments.

Scimar Deal Report

Get Kingscrowd's comprehensive report on Scimar including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Scimar is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Scimar deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge